Kilitch Drugs (India) Limited (NSE:KILITCH)
409.45
+51.80 (14.48%)
Apr 29, 2025, 2:30 PM IST
Kilitch Drugs (India) Revenue
Kilitch Drugs (India) had revenue of 561.66M INR in the quarter ending December 31, 2024, with 76.65% growth. This brings the company's revenue in the last twelve months to 1.82B, up 17.34% year-over-year. In the fiscal year ending March 31, 2024, Kilitch Drugs (India) had annual revenue of 1.54B with 10.58% growth.
Revenue (ttm)
1.82B
Revenue Growth
+17.34%
P/S Ratio
3.14
Revenue / Employee
10.83M
Employees
168
Market Cap
5.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 1.54B | 147.74M | 10.58% |
Mar 31, 2023 | 1.40B | 253.65M | 22.20% |
Mar 31, 2022 | 1.14B | 457.11M | 66.71% |
Mar 31, 2021 | 685.23M | 152.03M | 28.51% |
Mar 31, 2020 | 533.20M | -291.70M | -35.36% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |